Mirae Asset Global Investments’s C4 Therapeutics CCCC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.92K | Buy |
2,743
+368
| +15% | +$526 | ﹤0.01% | 1550 |
|
2025
Q1 | $4.16K | Buy |
2,375
+23
| +1% | +$40 | ﹤0.01% | 1520 |
|
2024
Q4 | $8.91K | Buy |
+2,352
| New | +$8.91K | ﹤0.01% | 1526 |
|
2024
Q2 | – | Sell |
-41,445
| Closed | -$260K | – | 1698 |
|
2024
Q1 | $260K | Buy |
+41,445
| New | +$260K | ﹤0.01% | 2168 |
|
2023
Q2 | – | Sell |
-17,467
| Closed | -$54.8K | – | 2615 |
|
2023
Q1 | $54.8K | Sell |
17,467
-29
| -0.2% | -$91 | ﹤0.01% | 2505 |
|
2022
Q4 | $103K | Buy |
17,496
+18
| +0.1% | +$106 | ﹤0.01% | 2447 |
|
2022
Q3 | $154K | Sell |
17,478
-4,641
| -21% | -$40.9K | ﹤0.01% | 2416 |
|
2022
Q2 | $749K | Buy |
+22,119
| New | +$749K | ﹤0.01% | 1561 |
|